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An individual has a limited set ofMHC alleles, but has the capacity to respond
to a broad range ofdifferent antigens. Thus, each MHC molecule has the capacity
to bind a large number ofdiverse antigens (1), perhaps through a single binding
site (2). In only a few cases (3-5), however, does a single antigenic peptide express
degenerate restriction on a variety ofunrelated class II MHC molecules.
Pigeon or moth cytochrome c (pcyt c or mcyt c)t show MHC restriction to var-
ious class II I-E molecules that have a conserved a chain (E~ and the (3 chain of
either the k, b, or s haplotype. There are only a few residue differences between
these haplotypes, in the antigen binding site, in that the I-E0 and I-E~chain differ
from the I-EJ6 chain at four and seven amino acid sequence positions, respectively
(6). The I-Ek-restricted T cell response to pcyt c is specific for a peptide within the
COOH-terminal sequence 88-104 (7). Anumberofpcyt c-specific hybridomas have
been shown to recognize the p88-104 andcloselyrelated m88-103 peptide, but have
different specificities for the E,6 chain of the I-E molecule (8, 9), in that each hy-
bridoma will recognize either the pigeon or moth peptide on at least two ofthree
different I-Ehaplotypes. Thus, Tcell hybridoma 22.D11 recognizes pcytcon B10A
APC (E~E~ and on B10.A(5R) APC (E#bE~, and has no response to mcyt c (8). T
cell hybridoma 2H10 will respond to pcyt c on B10.A and BIOS(9R) APC (EpE~,
and 2B4 will respond to mcyt c on B10.A and B10.A(5R) APC, and pcyt c only on
B10A APC (10). We have taken advantage of the ability of these three different T
cell hybridomas to recognize pcyt c or mcyt c peptides on these I-E molecules to
examine which residues in these determinants are used to bind the I-E molecules.
Using functional assays, MHC binding sites (designated agretopes) and TGR
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binding sites (designated epitopes) have already been defined for some antigen/TCR
systems, such as hen egg-white lysozyme (11) and for two similar pcyt c-specific T
cell clones (12). We have extended these studies by analyzing the recognition of single
residues in both pcyt c and mcyt c peptides on threedifferent I-E haplotypes by three
different T cell hybridomas. Using single amino acid-substituted peptide analogues
of the above two antigens, we have addressed the following questions. Given that
p88-104 and m88-103 are identical in their amino acid sequence, except for the de-
letion ofan alanine residue at position 103, do these two antigens use the same residues
as epitopes and/or agretopes? Is it possible that a single antigen can bind the MHC
molecule in more than one conformation and, if so, what role does the TCR play
in the binding pattern displayed by the peptide?
The interpretation of our results are based on criteria that define an epitope as
a residue in the determinant that, when altered, renders the analogue nonstimula-
tory but still permits it to compete with the native peptide for MHC binding and
an agretope as defined by Schwartz (7), i.e., a residue substitution that shifts the
relative potency of the analogue when presented by different MHC molecules. In
this paper we show that the reactivity patterns for the recognition ofpcyt c and mcyt
c by the three hybridomas, derived in this way, differ considerably, and that most
residues within 95-104 or 95-103 are used as epitopes or agretopes by at least one
ofthe TCR specificities. The distribution of these residues for each of the reactivity
patterns does not fall into a helical configuration for any of the reactivity patterns
observed, in contrast with studies on the T cell recognition of a lysozyme (11) and
myoglobin (13) peptide. Indeed, our findings suggest that not only do the moth and
pigeon peptides use a different set of agretopic residues to bind to the MHC mole-
cules, but that each peptide may interact with each MHC molecule in different con-
formations. Thus, a single class II MHC molecule appears to be able to present
the same peptide in different configurations, depending upon the TCR that makes
up the ternary complex.
Materials and Methods
Mice.
￿
B10.A (E*~, B10.A(5R) (ESE~, and B10.S(9R) (EhE~ mice were bred in the
vivarium at Scripps Clinic, La Jolla, CA.
Peptide Antigens.
￿
The synthetic peptides used in this study are shown in Figs. 1 and 2 .
They were either synthesized by the peptide synthesis facility of Scripps Clinic, under the
direction ofDr. Richard Houghten, by a modified procedure (14) of the standard solid-phase
peptide synthesis method (15), or in our laboratory as previously described (16). The crude
products were extracted in 15% aqueous acetic acid, lyophilized, and subsequently purified
to 98% purity by reverse-phase HPLC using a 1 x 25-cm Vydac C18 column (Sep/a/ra/tions
Group, Hesperia, CA) and gradients of acetonitrile (0-50% in 30 min) containing 0.1%
trifluoroacetic acid. Peptide compositions were verified using amino acid analysis.
Cell Lines.
￿
The B10.A anti-pcyt c T cell hybridomas, 2H10 (10) and 2134 (17) were ob-
tained from S. Hedrick, University of California, San Diego, CA. The B10.BR anti-pcyt c
T cell hybridoma 22 .1311 was produced in our laboratory (8). All three hybridoma lines were
recloned for high specific activity before use. The subclones used in this study were 2H10.a,
2B4.49, and 22.D11/h. The IL-2 growth-dependent line CTLL, originally derived by Gillis
and Smith (18), was obtained from S. Webb, Scripps Clinic. All the lines were maintained
in complete riedium containing DME (Irvine Scientific, SantaAna, CA) supplemented with
1017o FCS (HyClone Laboratories, Logan, UT), 10% NCTC-135 medium (Gibco Laborato-
ries, Grand Island, NY), 5 x 10-5 M a-mercaptoethanol, 4 mM glutamine, 50 U/ml peni-
cillin, 50 mg/ml streptomycin, and 6 mM Hepes.BHAYANI AND PATERSON
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Antigen-specific stimulation of T cell hybridomas was measured as the antigen-specific
release of IL-2 into the culture supernatant using IL-2-dependent CTLL cells (19). Briefly,
T cells (2 x 105) were incubated together with APC and various dilutions ofantigen for 24 h
at 37°C in 200 Al of complete media in 96-well flat-bottomed plates. Spleen cells (5 x
105/well) obtained from various strains were irradiated at 3,300 rad before they were used
as APC. At the end of a 24-h stimulation period, 50 Al of each culture supernatant was re-
moved and diluted to 200A] with complete media containing 5 x 103 CTLL cells/well. These
cells were cultured for 24 h at 37 °C, pulsed with 1 ACi of ['H]thymidine per well, and har-
vested 12 hlateron glass-fiber filter discsusing a Minimash cell harvester (M.A. Bioproducts,
Walkersvile, MD). Averages (cpm) of triplicate determinants for each peptide concentration
were plotted as dose-response curves from which the half-maximum values were calculated
and compared with that of the native peptides pcyt c 88-104 and mcyt c 88-103 .
Competition Assays.
￿
The analogues that were nonstimulatory at 100 AM/well in the direct
stimulation assay described above were added together with the native peptide to the APC
before the addition ofT cell hybridomas. The competition assays were carried out with 100
AM/well of the analogue and the titration ofthe native peptide from 20 /AM/well in the assay.
The effect of the analogue on the T cell response to the native peptide was observed as either
blocking or enhancement when a shiftin the half-maximum value ofthe native peptide was
observed. For some analogues there was no overall change.
Results
Three pcyt c-speck T Cell Hybridomas Show Marked Differences in theirFine Spec city
for Sequence 95-104. The experiments were carried out with the three T cell hy-
bridoma lines shownin Table I, which have previously been shown to have different
specificities for MHC (I-Ek)-restricted pcyt c and mcyt c responses (8-10) T cell hy-
bridoma 22.1311 recognizes pcyt c on B10.A APC (EX~ and on B10.A(5R) APC
(E#Ek
~), and does not respond to mcyt c at all. T cell hybridomas 2H10 and 2B4 are
also specific for pcyt c, but in addition, have a heteroclitic response to mcyt c on
B10.A APC with degenerate MHC restrictions (10).
In previous reports from our laboratory (8, 20) and others (21), it was established
that the minimal length of the pcyt c peptide required for T cell stimulation is the
COOH-terminal sequence containing residues 95-104. However, the addition of
residues to the NH2 terminus of residue 95 increases the antigenic potency of the
peptide; the maximal response is induced by pcyt c 88-104 (16). In the studies de-
scribed in this paper, we have used single amino acid-substituted synthetic peptides
of pcyt c (Fig. 1) and mcyt c (Fig. 2). All analogues had the same number of residues
with the sequence conserved from residues 88 through 94, but with single site sub-
stitutions introduced from positions 95 to 103/104 for mcyt c and pcyt c, respectively.
TABLE I
The Definition ofFunctional Phenotypesfor pcyt c-speck T Cell Hybridomas
P, pigeon cyt c; M, moth cyt c.
APC
Functional 1310 .A B10.A(5R) B10.S(9R)
T cell hybrid phenotypes (Eo kEa) (E$E.) (EpEg)
2134.49 1 P,M M -
2H10.a IIIa P,M - P
22.1311 IV P P -ide analogues
Peptide analogues
At least two substitutions were made for each position, one of which was selected
in orderto minimize changes in thecharge, hydrophobicity, or size ofthe analogues
relative to that of the native peptide. The other was to a hydrophobic residue with
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104
A K
K104R K - - - - - - - - - - - - - - -
A103K,K104A K - - - - - - - - - - - - - - K A
K104A K - - - - - - - - - - - - - - A A
A103K K - - - - - - - - - - - - - - K K
A1031 K - - - - - - - - - - - - - - I K
T102A K - - - - - - - - - - - - - A - K
T102S K - - - - - - - - - - - - - S - K
A1011 K - - - - - - - - - - - - I - - K
A101Y K - - - - - - - - - - - - Y - - K
Q100N K - - - - - - - - - - - N - - - K FIGURE 1. Pep
Q100A K - - - - - - - - - - - A - - - K of p88-104.
K99A K - - - - - - - - - - A - - - - K
K99R K - - - - - - - - - - R - - - - K
L98F K - - - - - - - - - F - - - - - K
L98A K - - - - - - - - - A - - - - - K
Y97A K - - - - - - - - A - - - - - - K
Y971 K - - - - - - - - I - - - - - - K
A96Y K - - - - - - - Y - - - - - - - K
A961 K - - - - - - - I - - - - - - - K
195A K - - - - - - A - - - - - - - - K
195Y K - - - - - - Y - - - - - - - - K
.88-103
88
K A E R A D L I A Y L K Q A T
103
K
K103A K - - - - - - - - - - - - - - A
T103R K - - - - - - - - - - - - - - R
T102V K - - - - - - - - - - - - - V K
T102A K - - - - - - - - - - - - - A K
A1011 K - - - - - - - - - - - - I - K
A101Y K - - - - - - - - - - - - Y - K
Q100N K - - - - - - - - - - - N - - K FIGURE 2.
Q100A K - - - - - - - - - - - A - - K of m88-103.
K99A K - - - - - - - - - - A - - - K
K99R K - - - - - - - - - - R - - - K
L98A K - - - - - - - - - A - - - K
L98F K - - - - - - - - - F - - - K
Y97A K - - - - - - - - A - - - - - K
Y971 K - - - - - - - - I - - - - - K
A96Y K - - - - - - - Y - - - - - - K
A961 K - - - - - - - I - - - - - - Kaconformational preference for thenative a-helicalconformation. Forthose sequence
positionsthat were not already alanine, the change was made to alanine, A. InFigs.
1 and 2, and in the text, we will refer to the peptides by denoting the substituted
residue, forexample, the peptide K104R has the native sequence 88-104 with a sub-
stitution of arginine for lysine at position 104.
The peptides were tested in vitro for their ability to stimulate the three T cell
hybridomas in the presence ofvarious APC. A representative dose-response curve
for the hybridoma 22.D11/h with p88-104, presented by B10.A APC, is shown in
Fig. 3 a. The half-maximum value of the native peptide was determined from the
dose-response curve as the concentration ofthe antigen required to stimulate 50%
ofthe maximal response of20,850 cpm, and the dose ofeach peptide to stimulate
11,000 cpm was obtained. The values obtained for analogues were normalized to
that ofthe native peptide p88-104. The data for the response ofT cell hybridoma
22.D11/h to pcytc analogues on B10.A or B10.A(5R) APC are summarized in Table
II. Most analogues lost their antigenic potency, even at the higher concentration
of100 uM/well (20 times the concentration ofthe native peptide required for max-
imal stimulation), except for the analogues with substitutions at positions 98 and
100 in the presence ofB10.A APC andat positions 98, 100, and 102 in the presence
of B10.A (5R) APC. Some ofthe nonstimulatory analogues had slight stimulatory
activity at 100,uM/well with half-maximum values that can be extrapolated to be
in therange of100-500(datanot shown). Withtheexceptionofthese slightlystimula-
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sentationto 22.Dll/h Tcells by BIO.A APC. (a)
Thenonstimulatory analogueswere addedtothe
culture at the same time as the native peptide
p88-104. (b) The native peptide was incubated
with the APC for5 h before the addition of the
analogue and the 22.Dll/h T cells. 88-104 (p)
half-maximum value, 0.6 AM (a); 1.0 AM (b);
88-104 + Y97A (+) half-maximum value, 0.24
AM (a); 0.41 AM (b); 88-104 + Y102S (p)half-
maximum value, 4.2 AM (a); 4.0 AM (b).
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tory peptides, all peptide analogues that were nonstimulatory at 100 AM/wellwere
used in competition with the native peptide 88-104 for presentation to the T cell
hybridomas, as described in Materials and Methods.
An example ofthe effect on the dose-response curve ofthe native peptide 88-104
on adding either ofthe two peptide analogues, T102S and Y97A, is shown in Fig.
3 a. In this experiment, the native peptide was titrated from 20 AM/well down to
0.032 AM/well in fivefold dilutions. The analogue, Y97A orT102S, was then added
to each row and the control wells in the absence of the native peptide. Irradiated
spleen cells were added and the plates were incubated for 2 h before 22.D11/h T
hybridoma cells were added. Fig. 3 a shows that the analogue T102S reduced the
recognition ofp88-104 (B in Table II) while the analogue Y97A enhanced the re-
sponse to p88-104 (E in Table II). Some ofthe peptide analogues had no effect on
TABLE II
Relative Concentration ofpcyt c Peptide Requiredfor Stimulation of
Phenotype IY T Cell Hybridoma 22.D11/h
` The behavior of the peptides in competition with p88-104. B, blocking; E,
enhancement; N, no effect; -, slight stimulatory activity, therefore not tested
in competition assay.
1 Maximum response of. p88-104 on B10.A, 20,000-40,000 cpm; p88-104 on
B10.A(5R), 10,000-20,000 cpm. Half-maximum value of p88-104 on B10.A,
0.1-1 juM; p88-104 on B10.A(5R), 2-8 jtM.
Peptide
B10.A
Relative
concentration
APC
B/E/N`
B10.A(5R)
Relative
concentration
APC
B/E/N
p88-104 11 lI
K104R ND 7.8
A103K, K104A >100 B >100 N
K104A >100 B >100 N
A103K >100 B >100 N
A1031 >100 B >100 N
T102A >100 - 0.2
T102S >100 B 48
AIOII >100 B >100
A101Y >100 B >100
Q100N 13 0.42
Q100A 2 0.27
K99A >100 B >100
K99R >100 B >100
L98F 1 .5 0.38
L98A 20 0.84
Y97A >100 E >100 N
Y971 >100 N >100 N
A96Y >100 - >100 N
A961 >100 N >100 N
195A >100 - >100
195Y >100 - >100BHAYANI AND PATERSON
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the recognition ofthe native peptide and are denoted as N in Table II. The weakly
stimulatory peptides, which were omitted from the competition experiments, are
denoted in Table II by a dash.
In otherexperiments, APC were preincubated with the native peptide(at arange
ofdilutions) for5 h before the addition ofthe nonstimulatory analogue(100p.M/well)
and the T cells. However, the later addition did not appear to change either the
blocking orenhancing ability ofapeptide analogue. Fig. 3 b showscompetition assays
forT102S andY97A performed inthisway. Wecould not demonstrateany significant
blocking or enhancing in the competition experiments with nonstimulatory ana-
logues performed using B10.A(5R) APC and the T cell hybridoma 22.D11/h. We
believethis maybebecauseoftheweaker response of22.D11/h top88-104onB10.A(5R)
cells.
Different Residues within 95-104 Serve asAgretopesorEpitopesfor the ThreeDifferent Hy-
bridomas. It has previously been shown that a residue may function as an epitope
defined as aTcell bindingsite, oran agretope, anMHC binding site, orboth simul-
taneously (12, 22-24). In our assays, we define an epitope as a residue, which when
substituted, renders the analogue nonstimulatory but still capable of blocking or
enhancing the response ofthe native peptide in a competition assay. Thus, the ana-
logue can compete atthe level ofMHC binding(agretope) and retainsthis function.
Applyingthis definition to the data shown in Table II, it canbe seen that examples
ofresidues that function as epitopes in the 22.D11/h response to p88-104 on B10.A
APC are residues 104, 103, 102, 101, 99, and 97.
An agretope is defined as a residue that shows a significant shift in relative con-
centration from one MHC (B10.A:En to another(B10.A [5R]:E~E~or BIOS[9R]:
EW~ when presented to the same T cell hybridoma (7). For example, the data in
Table II show that substituting an alanine for a threonine at residue 102 results in
achange in the half-maximum value ofthe peptide, T102A, from >100, using B10.A
APC, to 0.2 on B10.A(5R) APC. Thus, from Table II it can be seen that residues
98, 100, and 102 are agretopes for T cell hybridoma 22.D11/h. A schematic model
ofp88-104, as seen by 22.D11/h on B10.A and B10.A(5R) APC, is depicted in Fig.
4. It should be noted that a number of residue changes that abrogate recognition
by the T cell cannot be assigned either an epitopic or agretopic function based on
our criteria, and these are shown as U (unassigned) in Fig. 4.
Similarexperiments were carried out withTcell hybridomas 2H10.aand 2B4.49.
2H10.a responds to pcyt c on B10.A APC (E~E~ and BIOS (9R) APC (En, and
also responds to mcyt c on B10.A APC. The results, shown in Tables III and IV
and schematically presented in Fig. 4, define which residues appear to function as
epitopes and agretopes for T cell hybridoma 2H10.a when p88-104 analogues are
presented on B10.A and BIOS(9R) APC and whenm88-103 analogues are presented
on B10.AAPC. The residues97 and 102onm88-103, and97, 101, and 103 onp88-104,
were recognized as epitopes (Fig. 4). Since the response of2H10.a to mcyt c is re-
stricted to EKE«only, it was not possible to define agretopes on mcyt c using our
criteria, but for pcyt c, agretopic residues are 95, 97, 98, and 101.
T cell hybridoma 2B4.49, on the other hand, responds to pcyt c on B10.A APC
and mcyt c on B10.A and B10.A(5R) APC. Tables V and VI list the data ofdirect
stimulation assays and competition assays. It is interesting to note that no blocking
was observedwith anyofthe nonstimulatoryanalogues, butsome ofthem enhanced1616
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Pigeon cyt c as recognized by 22 .D11
95 96 97 98 99 100 101 102 103 104
U
￿
U
￿
3
￿
A
￿
IE
￿
A
￿
1&
￿
Z/A
￿
IE
￿
IE
Pigeon cyt c as recognized by 2H10.a
95 96 97 98 99 100 101 102 103 104
A U IB/A A U U IE/A U IE U
Moth cyt c as recognized by 2H10 .a
96 97 98 99 100 101 102 103
U IB U U U U IE U
Pigeon cyt c as recognized by 2114.49
95 96 97 98 99 100 101 102 103 104
U U 16 - IE U IE U - IIE
Moth cyl c as recognized by 2114.49
96 97 98 99 100 101 102 103
- U A U - IE U IE/A
FIGURE 4. A summary of epitope
and agretope assignments for the pcyt
c sequence 95-104 and the mcyt c se-
quence 95-103 for T cell hybridomas
22.D11, 2H10.a, and 2114.49. E, epi-
tope; A, agretope; U, insufficient data
to assign a function to this residue; and
-, no affect on T cell recognition.
theresponse ofthe native peptide. Wehave classified thoseresidues that on substitu-
tion resultedinsuch enhancement asepitopes. From Tables V andVI, andthe sum-
maryin Fig. 4, the data show that the 2B4.49 TCR interacts with residues 101 and
103 in m88-103 and 104, 101, 99, and 97 on the pigeon peptide. Agretopes 103 and
98 on the mcytcpeptide are definedon thebasis oftheshift in half-maximum value
between EKE. and EX~PC.
Fig. 4 summarizes allthedata shown in Tables II to VI, to facilitate acomparison
ofthe way in which sequences p95-104 and m95-103 are recognized by the three
differenthybridomas with respect to the residuesassigned as epitopes and agretopes.
Discussion
In this study we have analyzed peptide binding patterns ofthe pcyt c and mcyt
cpeptide antigens when in complexwith different MHCTCR combinations. These
antigens are restricted to MHC I-ES and to its congenic variants I-Eb and I-E~.
Upon injection into B10.A mice, they elicit a limited but diverse T cell repertoire
that uses a and a genes from a common pool of genes (25).
Pcyt c-specific T cells have been classified into five phenotypes according to their
fine specificities(9). In theexperiments described here, T cellhybridomas, 22.D11/h
(typeIV), 2H10.a(typeIIIa), and2B4.49 (type I)were used as respondercells(Table
I). To determine the epitopic residues, competition assays were set up in which the
native peptide and competing peptide were added together to the APC and the T
cells. When the APC were preincubated with the native peptide for 5 h, washed
three times in complete medium before the addition ofthe competing peptide, and
then assayed with the T cells, a very similar pattern ofblocking and enhancementBHAYANI AND PATERSON
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TABLE III
Relative Concentration ofpcyt c Peptide Requiredfor Stimulation of
Phenotype Ma T Cell Hybridoma 2H10.a
BIO.A APC
￿
BIO.S(9R) APC
The behavior of the peptides in competition with p88-104. B, blocking; E,
enhancement; N, no effect; -, slight stimulatory activity, therefore not tested
in competition assay.
Maximum response of: p88-104 on B10.A, 18,000-30,000 cpm; p88-104 on
B10.S(9R), 10,000-30,000 cpm. Half-maximum value of: p88-104 on B10.A,
0.5-5 AM; p88-104 on B10.S(9R), 0.25-8 AM.
was observed (compare Fig. 1, a and b). This result suggests that the analogues and
the native peptide have a similar affinity for the MHC molecule. In these competi-
tion experiments, it was not necessary to substitute peptides ofweak stimulatory
activity for the native peptide, orto use lower concentrations ofthe native peptide,
inordertodetect blockingby thenonstimulatory analogues, aswas reported inother
studies (26, 27).
We saw twoeffectsfrom the addition ofnonstimulatoryanaloguesinthe competi-
tion assays. In most cases a diminution in the response of the native peptide was
observed, which indicates that the nonstimulatory analogue competes with the na-
tivepeptide at theMHC-bindinglevel, hence, the agretope isintact and functional.
Alternatively, the presenceofnonstimulatory peptides sometimesresulted in anen-
Peptide
p88-104
K104R
A103K, K104A
Relative
concentration
1t
1 .6
1 .6
B/E/N'
Relative
concentration
it
1
0.4
B/E/N
K104A >100 - >100 N
A103K 0.3 0.9
A1031 >100 B >100 B
T102A >100 N >100 N
T102S >100 N >100
A1011 >100 - >100 N
AIOIY 6.6 >100 B
Q100N >100 - >100 N
Q100A 0.6 0.42
K99A >100 - >100
K99R >100 - >100
L98F 1 >100 ND
L98A >100 N 0.225
Y97A >100 E >100 N
Y971 >100 N 0.3
A96Y >100 N >100 N
A961 >100 - >100 N
195A >100 N >100 N
195Y >100 N 0 .32161 8
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TABLE IV
Relative Concentration of mcyt c Peptide Requiredfor Stimulation
of Phenotype Ma T Cell Hyhridoma 2H1Q.a
' The behavior of the peptides in competition with m88-103. B, blocking; E,
enhancement; N, no effect; -, slight stimulatory activity, therefore not used
in competition assay.
1 Maximum response ofm88-103 on B10.A, 20,000-25,000 cpm; half-maximum
value of m88-103 on B10.A, 0.1-5 pM.
hanced response of the native peptide. This observation, that nonstimulatory pep-
tides can enhance the recognition of the native sequence, is very surprising. The
mechanism by which enhancement can occur is under current investigation, but
one may speculate that the analogue may be involved in the reorientation of the
native peptide to facilitate a better contact with the TCR, or alternatively, that the
MHC groove can accommodate two peptides in an extended form that act in syn-
ergy to stimulate T cells. Either explanation argues against a single peptide binding
the MHC molecule, as proposed by others (2). In this study we have classified a
residue change that renders a peptide nonstimulatory, but has an enhancing effect
in competition assays with the native peptide, as an epitope, since the substitution
has clearly not affected the ability of the peptide to bind to the MHC.
For the T cell hybridoma 22 .D11/h, the residues 97, 99, 101, 102, 103, and 104
were found to be epitopes, which implies that a TCR of this specificity sees the pcyt
c peptide presented in a linear fashion. The epitopes and the agretopes of pcyt c
for 22.D11/h are shown in Fig. 4, in which residues 95 and 96 are unassigned (U)
because, although substitutions at these positions affected recognition, they could
not be classified by our criteria. From the above results, it is evident that the TCR
of T cell hybridoma 22.D11/h interacts with the last four residues of the pcyt c pep,
Peptide
m88-103
B10.A APC
Relative concentration
11
B/E/N"
K103A >100
K103R >100
T102V >100 B
T102A >100 ND
A101I >100 ND
A101Y >100 ND
Q100N >100
Q100A >100
K99A >100 N
K99R >100 N
L98F 7.8
L98A ND
Y97A >100 -
Y97I >100 B
A96Y 22.8
A96I 25BHAYANI AND PATERSON
TABLE V
Relative Concentration ofpcyt c Peptide Requiredfor Stimulation of
Phenotype I T Cell Hybridoma 2B4.49
' The behavior of the peptides in competition with p88-104. B, blocking; E,
enhancement; N, no effect; -, slight stimulatory activity, therefore not tested
in competition assay.
t Maximum response of p88-104 on BIO.A, 25,000-60,000 cpm; half-maximum
value of p88-104 on B10.A, 0.2-2 pM.
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tide. The epitopesatpositions 103 and 104mayplay animportantrolein this specificity
since the moth analogue, which differsfrom the pigeon peptide at positions 103 and
104, is not recognized by this T cell hybridoma (8, 9).
Similarexperiments withpcyt cpeptides on Tcell hybridomas 2H10.aand 2B4.49
are listed in Tables III and V. As was the case for 22.D11/h (Table II), it can be seen
thatalargenumberofthe analogueswere nonstimulatory. With2H10.acells, which
respond to p88-104 on B10.A and BIOS(9R) APC, most ofthe analogueswere non-
stimulatory at 100 jiM/ml. The agretopes were found to be in positions 97, 98, and
101, the epitopes at positions 97, 99, 101, and 103, andthe residues 96, 99, 100, 102,
and 104were not assignedto either classification (Table III and Fig. 4). Hybridoma
2B4does not respondto p88-104 on either B10.A(5R) or BIOS(9R) APC, therefore,
it was not possible to define the agretopes for the pigeon peptide usingour criteria.
The epitopes were found at positions 97, 99, 101, and 104 (Table V and Fig. 4).
Peptide
p88-104
B10.A APC
Relative concentration
It
B/E/N'
K104R 0.4
A103K, K104A ND
K104A >100 E
A103K 0.27
A103I 11
T102A >100 N
T102S 67
A101I >100 E
A101Y 29
Q100N >100
Q100A 2.5
K99A 11 .7
K99R >100 E
L98F 0.27
L98A 2.5
Y97A >100 E
Y97I >100 E
A96Y >100 -
A96I >100 N
I95A >100 N
I95Y ND1620
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TABLE VI
Relative Concentration of mcyt c Peptide Analogues Requiredfor
Stimulation of T Cell Hybridoma 2B4.49
" The behavior of the peptides in competition with m88-103 . B, blocking; E,
enhancement; N, no effect; -, slight stimulatory activity, therefore not tested
in competition assay.
1 Maximum response of: m88-103 on B10 .A, 15,000-60,000 cpm; m88-103
on B10.A(5R), 15,000-35,000 cpm. Half-maximum value of: m88-103 on
B10.A, 0.1-1 AM; m88-103 on B10.A(5R), 2-8 AM,
The failure ofT cells with the type I phenotype, such as 2134, to recognize pcyt
c when presented on B10.A(5R) cells has been attributed to the reduced ability of
p81-104 to interact with the I-Eb molecule, as compared with I-Ek. We have previ-
ously suggested (8) that the ability of 22.1311 to be stimulated by p81-104 on I-E0
expressingAPC argues against thisnotion. Our finding, inthese studies, thatdifferent
residues appear to be used as agretopes and epitopes by the three different pheno-
types, supports our previous hypothesis (8) that the interactionofp81-104 with I-E0
(but not I-Ek) masks the recognition ofresidues involved in TCR recognition ofT
cells of the type I phenotype but not for cells of the type IV phenotype.
Similar substitutions in m88-103 generated a set of peptides, as listed in Fig. 2,
andwere analyzed in a similarmanner on 2H10 and 2B4; 22.1311/h does not recog-
nize this peptide. The results ofthese experiments with 2H10.a are shown in Table
IV and Fig. 4, and those with 2B4.49 with B10A or BIOS(9R) APC are shown in
Table VI and Fig. 4. The epitopes of m88-103 seen by the two T cell hybridomas
arenotthe same. In addition, aparticular TCR (2H10.aor2B4.49) doesnot appear
to recognize the moth and pigeon peptides in the same configuration, as there is
little or no overlap of epitopes in the two peptides (Fig. 4).
Peptide
B10.A
Relative
concentration
APC
B/E/N'
BIO.A(5R)
Relative
concentration
APC
B/E/N
m88-103 It 1
K103A 3 .94 >100 E
A103R 51 .5 >100 E
T102V >100 - >100
T102A 23 17
Al01I >100 E >100
A101Y 98 >100
Q100N 9 .5 26.3
Q100A 3.4 1.05
K99A >100 - >100
K99R 84 28
L98F 1 .32 3.6
L98A 5.4 >100
Y97A >100 - >100
Y97I 84 >100
A96Y 0 .2 0 .7
A96I 1.03 3.6BHAYANI AND PATERSON
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These results show, first, that every residue between 95 and 104/103 contributes
to the antigenicity of the peptide for hybridomas 22.D11/h and 2H10.a, and that
there were only two residues (99 and 103 in p88-104 and 96 and 100 in m88-103)
in which substitutions had no effect on the recognition of 2B4.49. These residues
were not the same neutral residues as described by Fox et al. (12) for other type I
T cell specificities. In this study, in which a series ofanalogues between 98 and 104
were analyzed using T cell clones A.E7 and FLA2, residues 98 and 104 were found
to be neutral, residues 99-102 were defined as epitopic, and 100-103 were defined
asagretopic. Thecontrast between these findings and our ownemphasizethe diver-
sity ofrecognition ofa single peptide, even within T cellclones ofsimilar specificity.
A comparison ofthe finespecificitiesofT cell clones within the phenotypicclassifica-
tions ofI, III, IV, and V confirmsthis finding(Sorger, S. B., Y. Paterson, PJ. Fink,
and S. M. Hedrick, manuscript submitted for publication).
A second implication ofourfindings is thatthe residues ofany given peptide that
are used to interact with the MHC molecule are not fixed for every MHCTCR
interaction; that is, the samepeptidemay bind oneMHC molecule throughdifferent
sets ofagretopic residues, thus exposing different residues to different TCR. Thus,
the distribution ofepitopes for both the moth and pigeon peptide also varies for
each type ofTcell hybridoma. Asimilar conclusion was reached by Plachov et al.
(28) in studies on the fine specificity ofthe I-A"'-restricted T cell response to pig
insulin. These dataemphasizethe ternary nature ofthe MHCTCR-ligand interac-
tion and clearly rule out a static model ofT cell recognition, which assigns certain
invariantagretopicresidues tothe peptide by which it interacts with the MHC mol-
ecule independently ofthe TCR. Thus, our assignments ofthose residues that in-
teract with MHC or TCR are valid only for the particular trimolecular complex
from which they were derived.
Our findings are consistent with a requirement for the TCR in stabilizing the
complex, ashas been suggested by others (29, 30), and are in contrast with the pro-
posal that a single peptide associates with the Ia molecule in a specific conformation
(31) thatgeneratesTCR diversity byoverlapping epitopes being present on this single
molecular species. Indeed it has been suggested that T cell determinants are recog-
nized predominantly as amphipathic ct-helices, such that the residues contacting
the TCR lie on the hydrophilic face of the helix, while the agretopic residues are
arranged on the hydrophobic face (32, 33). If we arrange the assigned agretopes
and epitopes ofp95-104 (for the hybridomas 22.D11/h and 2H10.a) and m95-103
(for 2134.49) in a helical configuration (Fig. 5), there is no segregation ofagretopes
and epitopes on opposite faces of the helix of p95-104 for 22.1311/h and 2H10.a or
m95-103 for 2134.49. This strongly suggests that these Tcell determinants are not
recognized by thethree TCRs in a helicalconformation. These findingsare in agree-
ment with other studies from our laboratory (16, 34), which show that increasing
the helical propensity oftheTcell determinant 95-104 by adding non-native exten-
sions at the NH2 terminus does not result in improved recognition ofthe peptide
by the T cell hybridomas used in this study.
The promiscuity of peptide binding to MHC, in different conformations, may
explain the diversity in the fine specificity ofthe pcyt c- and mcyt c-specific T cell
clones. The expression of these clones varies quantitatively, that is, the phenotype
I isthemost commonly expressedT celltype. It isnot clearwhetherthere isapreferen-1622
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FtcuRE 5.
￿
Residue assignments sum-
marized in Fig. 4 plotted as a helical
wheel to illustrate the position ofagre-
topes and epitopes in the peptide if it
adopted an a-helical conformation.
The assignments for p88-014 are shown
for 22.DI1/h and 2H10.a. For 2B4.49,
for which agretope assignments can
only be made for m88-103, these are
shown.
tial selection of a particular V0 at the thymic level or whether the common expres-
sion of a particular TCR V/3 is a consequence of its preferential expansion due to
a particularly stable configuration of the TCRMHC-peptide complex. The latter
explanation seems more plausible if a peptide has the flexibility of binding in a va-
riety of ways, of which some are more stable than others.
Summary
The interaction of TCR, antigen, and MHC complex has been analyzed using
synthetic peptide antigens and a series of single amino acid-substituted analogues.
Two similar antigens, mouse cytochrome c (mcyt c) and pigeon cytochrome c (pcyt
c), elicit T cell responses in strains of mice bearing MHC class II EkE« (B10.A),
EbEk B10.A(5R)], and EWk n[B10.S(9R)]. The immunogenic regions of these an-
tigens are located in the peptide sequence p88-104 for pcyt c and m88-103 for mcyt
c. The limited T cell repertoire for these antigens is comprised of four groups of
T cell phenotypes that have very few differences in their TCR gene make up. In
this paper, we examine the diversity in their fine specificity for each of the antigens,
m88-103 and p88-104, complexed with each of the I-Ek haplotypes. Epitopes, i.e,
residues that interact with theTCR, and agretopes, i.e., residues in the MHC-binding
site, were assigned for the two peptide antigens in the presence of APC bearing EP
kEa, EKE., or E~Ea usingT cell hybridomas of the phenotypes I, IIIa, and IV. FromBHAYANI AND PATERSON
￿
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our results, we conclude that first, the substitution of any residue between 95 and
104 of the cytochrome c peptide changed the antigenic potency of the peptide for
at least one ofthe hybridomas. Second, each T cell type has a different recognition
pattern ofepitopes and agretopes for a particular antigen-MHC complex, thus, ruling
out a static model of T cell recognition, which assigns certain, invariant agretopic
residues to the peptide by which it interacts with the MHC molecule independently
of the TCR. Third, the same T cell hybridoma responded to the antigens differently
when presented on various MHC molecules, implying that overall changes in the
MHC groove, as displayed by the three haplotypes, may affect the efficiency in binding
the peptide. Fourth, since most of the residues are used as epitopes by at least one
ofthe T cell specificities, the peptide appears to be recognized in a different confor-
mation by each T cell hybridoma phenotype; and, finally, the epitopic and agretopic
residues do not segregate, for any one of the T cell specificities, in such a way that
suggests they are recognized in a helical conformation. In summary, our results sug-
gest that a single peptide may generate diversity in the T cell response by virtue
of its conformational flexibility within the TCR-MHC-antigen complex.
We thankDrs. Helen Cooper andJim Collawn, Scripps Clinic, and Simona Sorger and Dr.
Stephen Hedrick, University of California, San Diego, for very helpful comments on these
studies.
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